DYN(Dyne Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-13 | Friedl-Naderer Johanna | Chief Commercial Officer | 公开市场卖出 | 231 | $16.82 |
| 2026-11-13 | Kerr Douglas | Head of R&D and CMO | 公开市场卖出 | 2,604 | $16.82 |
| 2026-11-13 | Lucera Erick | Chief Financial Officer | 公开市场卖出 | 1,991 | $16.82 |
| 2026-11-13 | Cox John | CEO & President | 公开市场卖出 | 5,513 | $16.82 |
| 2026-10-02 | Posner Brian S | 董事 | 公开市场买入 | 2,500 | $16.00 |
| 2026-09-08 | Friedl-Naderer Johanna | Chief Commercial Officer | 公开市场卖出 | 185 | $18.88 |
| 2026-09-08 | Kerr Douglas | Chief Medical Officer | 公开市场卖出 | 1,290 | $18.88 |
| 2026-09-08 | Cox John | CEO & President | 公开市场卖出 | 5,658 | $18.88 |
| 2026-09-04 | Friedl-Naderer Johanna | Chief Commercial Officer | 公开市场卖出 | 900 | $24.35 |
| 2026-09-04 | Kerr Douglas | Chief Medical Officer | 公开市场卖出 | 3,745 | $24.35 |
| 2026-08-14 | Rhodes Jason P | 董事 | 公开市场卖出 | 322,465 | $25.00 |
| 2026-08-14 | Rhodes Jason P | 董事 | 公开市场卖出 | 478,377 | $25.00 |
| 2026-08-14 | Rhodes Jason P | 董事 | 公开市场卖出 | 1,359,674 | $25.00 |
| 2026-08-13 | Friedl-Naderer Johanna | Chief Commercial Officer | 公开市场卖出 | 226 | $26.28 |
| 2026-08-13 | Kerr Douglas | Chief Medical Officer | 公开市场卖出 | 1,556 | $26.28 |
| 2026-08-13 | Lucera Erick | Chief Financial Officer | 公开市场卖出 | 1,797 | $26.28 |
| 2026-08-13 | Rhodes Jason P | 董事 | 公开市场卖出 | 63,643 | $26.20 |
| 2026-08-13 | Rhodes Jason P | 董事 | 公开市场卖出 | 94,415 | $26.20 |
| 2026-08-13 | Rhodes Jason P | 董事 | 公开市场卖出 | 268,354 | $26.20 |
| 2026-08-13 | Cox John | CEO & President | 公开市场卖出 | 4,986 | $26.28 |